James Stankiewicz

964 total citations
14 papers, 694 citations indexed

About

James Stankiewicz is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Neurology. According to data from OpenAlex, James Stankiewicz has authored 14 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 6 papers in Molecular Biology and 3 papers in Neurology. Recurrent topics in James Stankiewicz's work include Multiple Sclerosis Research Studies (10 papers), Peripheral Neuropathies and Disorders (3 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). James Stankiewicz is often cited by papers focused on Multiple Sclerosis Research Studies (10 papers), Peripheral Neuropathies and Disorders (3 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). James Stankiewicz collaborates with scholars based in United States and Italy. James Stankiewicz's co-authors include Mohit Neema, Steven D. Brass, Howard L. Weiner, Brian C. Healy, Antonia Ceccarelli, Rohit Bakshi, Ashish Arora, Zachary D. Guss, Roopali Gandhi and Stephanie Tankou and has published in prestigious journals such as Neurology, Annals of Neurology and Neurobiology of Aging.

In The Last Decade

James Stankiewicz

14 papers receiving 687 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Stankiewicz United States 11 341 245 104 83 82 14 694
Daisuke Noto Japan 12 332 1.0× 72 0.3× 15 0.1× 104 1.3× 45 0.5× 20 636
Achilles Ntranos United States 12 279 0.8× 223 0.9× 10 0.1× 56 0.7× 37 0.5× 15 556
Donna Grant United Kingdom 14 137 0.4× 241 1.0× 32 0.3× 112 1.3× 211 2.6× 22 745
Jiangtao Jin China 10 504 1.5× 46 0.2× 48 0.5× 215 2.6× 25 0.3× 15 1.0k
Tamires Flauzino Brazil 16 148 0.4× 294 1.2× 12 0.1× 65 0.8× 89 1.1× 44 719
Ata Abbasi Iran 14 174 0.5× 79 0.3× 11 0.1× 63 0.8× 25 0.3× 56 618
Sang Tae Kim South Korea 18 121 0.4× 72 0.3× 128 1.2× 63 0.8× 54 0.7× 82 808
Yasuhiro Hasegawa Japan 16 251 0.7× 259 1.1× 58 0.6× 98 1.2× 137 1.7× 96 1.1k
Miho Mizuno Japan 8 295 0.9× 48 0.2× 9 0.1× 107 1.3× 8 0.1× 9 546

Countries citing papers authored by James Stankiewicz

Since Specialization
Citations

This map shows the geographic impact of James Stankiewicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Stankiewicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Stankiewicz more than expected).

Fields of papers citing papers by James Stankiewicz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Stankiewicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Stankiewicz. The network helps show where James Stankiewicz may publish in the future.

Co-authorship network of co-authors of James Stankiewicz

This figure shows the co-authorship network connecting the top 25 collaborators of James Stankiewicz. A scholar is included among the top collaborators of James Stankiewicz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Stankiewicz. James Stankiewicz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Stankiewicz, James, et al.. (2021). Review of Phase III Clinical Trials Outcomes in Patients with Secondary Progressive Multiple Sclerosis. Multiple Sclerosis and Related Disorders. 54. 103086–103086. 5 indexed citations
2.
Liu, Yanqing, et al.. (2021). Effectiveness and safety of dimethyl fumarate in progressive multiple sclerosis. Multiple Sclerosis Journal - Experimental Translational and Clinical. 7(2). 3080374032–3080374032. 5 indexed citations
3.
Tankou, Stephanie, Keren Regev, Brian C. Healy, et al.. (2018). Investigation of probiotics in multiple sclerosis. Multiple Sclerosis Journal. 24(1). 58–63. 107 indexed citations
4.
Tankou, Stephanie, Keren Regev, Brian C. Healy, et al.. (2018). A probiotic modulates the microbiome and immunity in multiple sclerosis. Annals of Neurology. 83(6). 1147–1161. 190 indexed citations
5.
Sattarnezhad, Neda, Brian C. Healy, Moogeh Baharnoori, et al.. (2017). Dimethyl fumarate versus interferon for treatment of relapsing-remitting multiple Sclerosis (P6.381). Neurology. 88(16_supplement). 1 indexed citations
6.
Baharnoori, Moogeh, Cindy Gonzalez, Alicia S. Chua, et al.. (2017). Predictors of hematological abnormalities in multiple sclerosis patients treated with fingolimod and dimethyl fumarate and impact of treatment switch on lymphocyte and leukocyte count. Multiple Sclerosis and Related Disorders. 20. 51–57. 16 indexed citations
7.
Kim, Gloria, Renxin Chu, Shahamat Tauhid, et al.. (2017). Sample size requirements for one-year treatment effects using deep gray matter volume from 3T MRI in progressive forms of multiple sclerosis. International Journal of Neuroscience. 127(11). 971–980. 11 indexed citations
8.
Khalid, Fariha, Shahamat Tauhid, Alicia S. Chua, et al.. (2016). A longitudinal uncontrolled study of cerebral gray matter volume in patients receiving natalizumab for multiple sclerosis. International Journal of Neuroscience. 127(5). 396–403. 10 indexed citations
9.
Stankiewicz, James, Mohit Neema, & Antonia Ceccarelli. (2014). Iron and multiple sclerosis. Neurobiology of Aging. 35. S51–S58. 87 indexed citations
10.
Healy, Brian C., Bonnie I. Glanz, James Stankiewicz, et al.. (2010). A method for evaluating treatment switching criteria in multiple sclerosis. Multiple Sclerosis Journal. 16(12). 1483–1489. 16 indexed citations
11.
Arora, Ashish, Mohit Neema, James Stankiewicz, et al.. (2008). Neuroimaging of Toxic and Metabolic Disorders. Seminars in Neurology. 28(4). 495–510. 10 indexed citations
12.
Stankiewicz, James & Steven D. Brass. (2008). Role of iron in neurotoxicity: a cause for concern in the elderly?. Current Opinion in Clinical Nutrition & Metabolic Care. 12(1). 22–29. 76 indexed citations
13.
Neema, Mohit, James Stankiewicz, Ashish Arora, Zachary D. Guss, & Rohit Bakshi. (2007). MRI in Multiple Sclerosis: What’s Inside the Toolbox?. Neurotherapeutics. 4(4). 602–617. 64 indexed citations
14.
Neema, Mohit, James Stankiewicz, Ashish Arora, et al.. (2007). T1‐ and T2‐Based MRI Measures of Diffuse Gray Matter and White Matter Damage in Patients with Multiple Sclerosis. Journal of Neuroimaging. 17(s1). 16S–21S. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daisuke Noto Breakdown of academic impact, for papers by Achilles Ntranos Breakdown of academic impact, for papers by Donna Grant Breakdown of academic impact, for papers by Jiangtao Jin Breakdown of academic impact, for papers by Tamires Flauzino Breakdown of academic impact, for papers by Ata Abbasi Breakdown of academic impact, for papers by Sang Tae Kim Breakdown of academic impact, for papers by Yasuhiro Hasegawa Breakdown of academic impact, for papers by Miho Mizuno
Rankless by CCL
2026